426686007: Erlotinib hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\...

\Epidermal growth factor receptor inhibitor\Erlotinib hydrochloride (substance)

\Protein-tyrosine kinase inhibitor\Erlotinib hydrochloride (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Erlotinib hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Substance with ether structure\Erlotinib hydrochloride (substance)

\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Erlotinib hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2662883016 Erlotinib hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2674714014 Erlotinib hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

45091000188117 erlotinib chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

809381000172110 chlorhydrate d'erlotinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erlotinib hydrochloride (substance)	Is a	Erlotinib (substance)	false	Inferred relationship	Some
Erlotinib hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Erlotinib hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Erlotinib (substance)	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	éther	false	Inferred relationship	Some
Erlotinib hydrochloride (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1
Erlotinib (as erlotinib hydrochloride) 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erlotinib hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets